4//SEC Filing
Smith Ernest S. 4
Accession 0000891839-19-000049
CIK 0001205922other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 5:04 PM ET
Size
9.0 KB
Accession
0000891839-19-000049
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Smith Ernest S.
SVP, Research & CSO
Transactions
- Award
Stock Option (Right to Buy)
2019-03-15+8,000→ 8,000 totalExercise: $3.90Exp: 2029-03-14→ Common Stock (8,000 underlying)
Holdings
- 5,110
Stock Option (Right to Buy)
Exercise: $7.10Exp: 2025-12-23→ Common Stock (5,110 underlying) - 40,729
Stock Option (Right to Buy)
Exercise: $7.10Exp: 2025-12-22→ Common Stock (40,729 underlying) - 16,000
Common Stock
Footnotes (3)
- [F1]Exercisable in full as of the date of this report.
- [F2]This option has vested with respect to 4,088 shares and the remainder vests on December 23, 2019.
- [F3]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date.
Documents
Issuer
VACCINEX, INC.
CIK 0001205922
Entity typeother
Related Parties
1- filerCIK 0001747769
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 5:04 PM ET
- Size
- 9.0 KB